CD86 and neoplasm: Butyric acid enhanced granulocytic maturation of AML cells [214], and just like other HDACi, induced expression of costimulatory and adhesion molecules (CD80, CD86, HLA-DR, HLA-ABC, and ICAM-1) in AML cells, inducing anti-tumor immune responses [209].